Immunosuppressive therapy in patients with aplastic anemia: a single-center retrospective study.
Aplastic anemia (AA) is a rare disease in which hematopoietic stem cells are severely diminished resulting in hypocellular bone marrow and pancytopenia. Etiology of AA includes auto immunity, toxins, infection, ionizing radiation, drugs and rare genetic disorders, but in the majority of cases no cau...
Main Authors: | Hasan Jalaeikhoo, Ahmad Khajeh-Mehrizi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4430492?pdf=render |
Similar Items
-
Aplastic anemia: immunosuppressive therapy in 2010
by: Antonio M. Risitano, et al.
Published: (2011-06-01) -
Thymoma followed by aplastic anemia: two different responses to immunosuppressive therapy
by: Murilo Antunes de Castro, et al.
Published: (2011-12-01) -
Efficacy and safety of immunosuppressive therapy in the treatment of seronegative hepatitis associated aplastic anemia
by: Chen HF, et al.
Published: (2014-09-01) -
The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia
by: A A Ganapiyev, et al.
Published: (2010-07-01) -
Acquired aplastic anemia in childhood: single-center experience
by: M. Bilici, et al.
Published: (2020-10-01)